I received this e-mail from Biozoom today after sending an e-mail to them asking the status of the SEC investigation.
We share your concern regarding biozoom’s stock. We understand your frustration that more information is not available and hope you can appreciate that we have been reticent to release information to the public without knowing precisely what occurred.
At this date, it appears that the prior owners and control persons of the company and certain third parties may have been involved in unlawful sales of company stock to the public after the completion of the material acquisition of the biozoom technology this past March.
As you know, our current officers and directors, Mr. Hoheisel and Dr. Köcher, were the developers of this technology over many years after spending substantial time, resources, and expertise developing the technology. At the time of the closing of the acquisition, they did not know that the former owners and control persons and third parties had or controlled “free-trading” stock that they would be selling into the market for their unjust enrichment. We assure you that Mr. Hoheisel and Dr. Köcher would not have closed on the acquisition had they known that an unlawful distribution would occur.
We are currently exploring our legal options while we are continuing to provide documentation to the SEC to address the questions that they have, and we will provide you additional updates as we are able.
Thank you once again for your patience during this process.
biozoom services GmbH
Wilhelmshöher Allee 273A
D-34131 Kassel
